DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Rachel Webster M.Sc., D.Phil., manages and leads a team of oncology business insights analysts in producing syndicated primary and secondary market research reports and custom analysis on a wide range of oncology indications. Dr. Webster also provides client support for all oncology products and assists global biopharmaceutical companies uncover strategic opportunities through data-driven insights from a variety of channels.

Dr. Webster has ten years of experience in market forecasting and has a broad knowledge of oncology indications and markets; she has particular interest and expertise in immuno-oncology. Additionally, Rachel has published numerous oncology market assessment articles in Nature Reviews Drug Discovery.

Prior to joining DRG, Rachel was a Research Scientist at Immunocore in the target validation group where her research focused on identifying target antigens expressed in cancers.

 

 

Available as a speaker

Contact Us About Your Event